Human papillomavirus awareness among HIV-infected drug users in two urban areas

Abstract

Summary

Human papillomavirus (HPV) is the cause of cervical and anal cancer. Human immunodeficiency virus (HIV) infection and cocaine use are associated with increased risk for HPV infection and associated diseases, but little is known about HIV-infected drug users' awareness of HPV. We investigate HPV awareness among HIV-infected, sexually-active crack cocaine users from two inner-city hospitals in Florida and Georgia during their inpatient stays. Multivariate logistic regression analysis was used to examine potential correlates of HPV awareness. We interviewed 215 participants (110 women; 105 men) about their awareness of HPV infection. Overall, only 25% of respondents reported having heard of HPV. The odds of having heard of HPV were greater for respondents having a high-school degree or higher, having ever gone to an HIV provider for HIV care, and having two or more sexual partners. Despite increased susceptibility to HPV infection and HPV-related cancers, our study findings suggest that sexually-active HIV-infected crack cocaine users have little awareness of HPV and highlight the need for programmes targeting HPV education for HIV-infected crack cocaine drug users.

Keywords

HIV AIDS sexually transmitted infection human papillomavirus HPV knowledge anal cancer cervical cancer drug users crack cocaine

Get full access to this article

View all access options for this article.

References

Cates

Jr . American Social Health Association. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999; 26: S 2–7.

Koutsky

. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102: 3–8.

Daling

Madeleine

Johnson

. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101: 281–288.

Palefsky

. Human papillomavirus-associated malignancies in HIV positive men and women. Curr Opin Oncol 1995; 7: 437–441.

Patel

Hanson

Sullivan

. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Int Med 2008; 148: 728–736.

International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in immunodeficiency virus-infected adults. JNCI 2000; 92: 1823–1830.

Frisch

Biggar

Goedert

. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. JNCI 2000; 92: 1500–1510.

Diamond C, Taylor TH and Culver HA. Dramatic increase in anal cancer diagnosis in the era of highly active antiretroviral therapy. In: 11th conference on retroviruses and opportunistic infections, San Francisco, CA, 2004.

Bower

Powles

Newson-Davis

. HIV-associated anal cancer: has highly antiretroviral therapy reduced the incidence or improved the outcome? JAIDS 2004; 37: 1563–1565.

10.

Edlin

Irwin

Faruque

. Intersecting epidemics-crack cocaine use and HIV infection among inner-city young adults. Multicenter crack cocaine and HIV infection study team. N Engl J Med 1994; 331: 1422–1427.

11.

Shen

Luo

Hagen

. Immunomodulating activities of cocaine- evaluation of lymphocyte transformation related to other immune functions. Int J Immunopharmacol 1994; 16: 311–319.

12.

Starec

Rouveix

Sinet

. Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus. J Pharmacol Exp Thers 1991; 259: 745–750.

13.

Avila

Morgan

Bayer

. Stress-induced suppression of the immune system after withdrawal from chronic cocaine. J Pharmacol Exp Ther 2003; 305: 290–297.

14.

Minkoff

Zhong

Strickler

. The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women. Infect Dis Obstet Gynecol 2008; 58: 70–82.

15.

Pitts

Clarke

. Human papillomavirus infections and risks of cervical cancer: What do women know? Health Educ Res 2002; 17: 706–714.

16.

Ramirez

Ramos

Clayton

. Genital human papillomavirus infections: Knowledge, perception of risk, and actual risk in a non-clinic population of young women. J Womens Health 1997; 6: 113–121.

17.

Vail-Smith

White

. Risk level, knowledge, and preventive behavior for human papilllomaviruses among sexually active college women. J Am Coll Health 1992; 40: 227–230.

18.

Giles

Garland

. A study of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines. Aust N Z J Obstet Gynaecol 2006; 46: 311–315.

19.

Hosmer

Lemeshow

. Applied logistic regression, New York, NY: John Wiley and Sons, 2000.

20.

Bell

Metsch

Vogenthaler

. Never in care: characteristics of HIV-infected crack cocaine users in 2 US cities who have never been to outpatient HIV care. JAIDS 2010; 54: 376–380.

21.

Mellins

Havens

McDonnell

. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care 2009; 21: 168–177.

22.

Anthony

Gardner

Marks

. Factors associated with use of HIV primary care among persons recently diagnosed with HIV: examination of variables from the behavioral model of health-care utilization. AIDS Care 2007; 19: 195–202.

23.

Napravnik

Eron

McKaig

. Factors associated with fewer visits for HIV primary care at a tertiary care center in the Southeastern US. AIDS Care 2006; 18: 45–50.

24.

Markowitz

Dunne

Saraiya

. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56: 1–24.

25.

Giuliano

Palefsky

Goldstone

. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 2011; 364: 401–411.